SlideShare a Scribd company logo
1 of 39
MS PRACTICE GUIDELINES
Dr prashant shringi
AAN recommendations April 23, 2018
ECTRIMS/EAN Guideline on the pharmacological treatment of people
with multiple sclerosis2017
1. When to start treatment? –DMT Various subtypes of
MS,CIS, RIS
2. Monitoring treatment ?
3. when to switch-DMT?
4. Acute & symptomatic T/t
5. when to stop?
6. Add on drugs or second line drugs for inadequate
response or frequent relapses?
7. Special situations –childhood MS,pregnancy,elderly
8. monitoring of individual drug
9. Follow up
Q1.When to start treatment? –DMT for Various
subtypes of MS,CIS, RIS
• Clinically isolated syndrome(CIS)
• No / yes
• Serial imaging at least annually for the first five years and
close follow-up rather than initiating DMT in people with CIS
• Offer IFN or glatiramer to patients with CIS and an abnormal
MRI with lesions suggestive of MS who do not fulfil criteria
for MS (EAN)
• First clinical episode ,an event or precedent history that is
suggestive of demyelination lasts at least 24hrs and occurs in
the absence of fever, infection or encephalopathy
• Radiologicallyisolated sydrome(RIS)
• No
• 34% of patients with RIS develop a first acute clinical event
consistent with CIS within 5 years
• Incidental brain or spinal cord MRI findings that are highly
suggestive of MS in an asymptomatic patient lacking any
history ,symptoms or signs of multiple sclerosis
DMT for MS
• When to start for MS-
 fulfilling criteria for MS(Revised Mcdonald’s criteria ,
MAGNIMS 2016 criteria)
 Active lesion on MRI- evidence of inflammation
 After discussing the risks and benefits, DMT should be
prescribed to people with a single clinical demyelinating event
and ≥2 brain lesions characteristic of MS who decide they
want this therapy
 should offer DMTs to people with relapsing forms of MS with
recent clinical relapses or MRI activity
Not to start DMT
• Serial imaging at least annually for the first five years and
close follow-up rather than initiating DMT in people with-
 no relapses in the last two years,
 no active new MRI lesion
Which DMT should start ?
• ascertain preferences in terms of safety, route of
administration, lifestyle, cost, efficacy, AEs and tolerability in
the choice of DMT- pt choice
• DMTs are prescribed to reduce relapses and new MRI lesion
activity and not for symptom improvement in people with MS
• Started with –
• INF
• glatemir
• Highly active MS - prescribe alemtuzumab, fingolimod, or
natalizumab
• In pt of MS who are candidates for DMTs who do not have access
to approved DMTs azathioprine or cladribine should started
• Mitoxantrone- Because of the high frequency of severe AEs,
clinicians should not prescribe to people with MS unless the
potential therapeutic benefits greatly outweigh the risks
• SPMS
• First rule out other causes of progressive disability in MS-
• Mitoxantrone –FDA approved
• High dose interferon beta
• Almetuzumab
• Cyclophosphamide
• Cladrbinre
• Rituximab ???
• Pulse steroids NO
• Ivig
• PPMS
• should offer ocrelizumab to people with PPMS who
are ambulatory
• March 2017
• Anti-CD20 mab designed to optomize cell depletion
 300mg infusion given 14 days apart(total-600mg) for
atleast 120 weeks
 C/I in hepatitis B infection
Monitoring treatment ?
Assesment efficacy of treament
• Consider combining MRI with clinical measures when
evaluating disease evolution in treated patients
• When monitoring treatment response in patients
treated with DMDs, perform a reference brain MRI
usually within 6 months of treatment onset and
compare it with a further brain MRI performed
typically 12 months after starting treatment
• When monitoring treatment response,
measurement of new or unequivocally enlarging
T2 lesions is the preferred MRI method
supplemented by GAD enhancing lesions for
monitoring treatment response
When monitoring treatment safety, perform brain MRI yearly
in low risk and 3-6 monthly in high risk PML patients
Add on drugs or second line drugs for inadequate
response or frequent relapses?
when consider to switch-DMT?
• In following condition one can swtich DMT-
• 1. When any pt using a DMT long enough for the
treatment to take full effect and are adherent to
their therapy when they experience-
one or more relapses
two or more unequivocally new MRI-detected lesions
increased disability on examination, over a one-year period of
using a DMT
when consider to switch-DMT?
1. change to noninjectable or less frequently injectable DMTs
who report intolerable discomfort with the injections or in
those who report injection fatigue on injectable DMTs
2. switch DMT or reducing dosage or frequency when there are
persistent laboratory abnormalities
3. If a patient develops malignancy or oppurtunistic infection
while using a DMT
4. Natalizumab- -pt who have infusion reactions and who
experience breakthrough disease activity - should switch
DMTs if they have persistent antibodies, check natalizumab
antibodies
when consider to switch-DMT?
• Physician -counsel people considering natalizumab
discontinuation that there is an increased risk of MS relapse
within six months of discontinuation Level A
• initiate treatment(fingolimod, rituximab) within eight to 12
weeks after natalizumab discontinuation
When to stop DMT in MS pt ?
1. Pregnancy
2. Trial off therapy- stable MS
3. SPMS-pt who do not have ongoing relapses (or
gadolinium-enhanced lesions on MRI activity) and
have not been ambulatory (EDSS 7 or greater) for at
least two years. Level C
4. CIS- Clinicians should review the associated risks of
continuing DMTs versus those of stopping DMTs
LevelB
Acute & symptomatic T/t
• Treatment of acute relapse
 IV methylprednisolone (first line therapy)
 Plasma exchange (second line therapy)
• 5-7 exchanges recommeded on every 2 days, 30-
50ml/kgw
Who do not respond to glucocorticoids
 Cognitive impairment-DMT
 Depression-Duloxetine,escitalopram
 Fatigue:Amantidine,Modafinil,Dextroamphetamine,methylpheni
 Gait impairment:Dalfampridine (K channel blocker) 10 mg bd,
• C/I-if seizure history
 Heat intolerance-Dalfampridine
 Paroxysmal symptoms- Carbamazepine(CBZ)
 Lhermitte sign-gabapentin,pregaba,CBZ
 Spasticity- Tizantidine, baclofen, dantrolone, clonezepam
Special situations
• Pregnancy –
• All DMTs are not licensed during pregnancy, except
glatiramer,INF
• counsel women to stop their DMT before conception for
planned pregnancies and should not initiate DMTs during
pregnancy unless the risk of MS activity during pregnancy
outweighs the risk associated with the specific DMT during
pregnancy
• Pregnancy – immunomodulatory effect on MS – decreased
relapse rate
• EAN
women with persistent high disease activity, advise to delay
pregnancy. If despite this advice, still decide to become
pregnant:
 treatment with natalizumab throughout pregnancy may be
considered
 treatment with alemtuzumab could be an alternative,
provided that a 4-month interval is strictly observed from the
latest infusion until conception
• Breast feeding – DMT should be Stop
• OCP- can be used in MS
• Some studies- OCP reduced relapse
• Chidhood MS:
• 6-18% before 18 yr
• First symptom ADEM like presentation –relapse-MS
• Female=male
• Nearly always RRMS type
• Relapse rate is more than adults
• Prognosis is good than adult MS
• Treatment – same as adult MS
Dose & monitoring of individual drug
• INF:
• Interferon beta-1b 8 mIU subcutaneous alternate day
• Interferon beta-1a 30 micrograms IM weekly
• Interferon beta-1a 44 micrograms subcutaneous 3 times per
week
• A/E: Postinjection flulike symptoms Depression, suicidal
ideation, or psychosis. Hepatic injury, Anaphylaxis, Decreased
peripheral blood counts
• Monitoring : CBC, LFT
• Glatiramer Acetate:
• 40 mg SQ injection TIW
• A/E: Lipoatrophy and skin necrosis,Postinjection reaction -
flushing, chest pain, palpitations, anxiety, dyspnea, throat
constriction, or urticaria
• No laboratory monitoring is neccessary
• Natalizumab: infusion
• 300 mg IV over one h every 4 wk
• A/E: Anaphylaxis .Risk of PML.Herpes encephalitis or
meningitis,Hepatotoxicity
• Monitoring : JC virus ab in every months
• Fingolimod:oral 0.5mg/day
• A/E: bradycardia, herpesvirus infections, basal cell skin cancer,
macular edema, and abnormal pulmonary function test
• Monitoring : CBC, pre-screening for VZV immunity, ophthalmologic
evaluation to screen for macular edema, and ECG testing to rule out
cardiac conduction abnormalities
Teriflunomide:7 or 14 mg RRMS
A/E :Increased blood pressure,Alopecia, nHeadache, Diarrhea, Severe
liver injury.
Monitoring: patients should be screened for latent tuberculosis and
women of childbearing potential should undergo pregnancy testing.
Liver function tests should be obtained monthly during the first 6
months of treatment, and intermittently thereafter.
• Dimethyl fumarate
• 240 mg BD/TDS
• A/E:lymphopenia , Flushing, abdominal pain, and diarrhea,
Angioedema and anaphylaxis
• Monitoring :CBC
Follow up
Clinical follow up –acute attacks
Cognitive assessment
EDSS every 3 months
MRI every 12 months
Modified Rio score
Newer therapeutic agents
S1P Receptor Modulators
Siponimod ,ozanimod
Anti-LINGO ab: opicinumab
Idebenone
 MIS416
Ofatumumab:anti CD 20 antibody
• Risk of developing PML in JC ab negative pt on
natalizumab ?
• 10-20% annualy
• 2-3% annualy
• 50% annualy
• No risk
• Which drug not required laboratory
montoring?
• Teriflunamide
• Inf
• Glatemir
• Alemetezumab
• Highly active MS which drug is beneficial?
• Inf
• Azathipirone
• Fingolimod
• Glatemir
• 40 year old female develpoed one attack of
MS started on DMT improved developed 2
attack after 1 year than DMT switched but her
weakness worsen continiously , CONTRAST
MRI showed no new lesions what next?
• Add 2 line drug
• Continue same DMT
• Start ocrelizumab
• Nothing
• Thank you

More Related Content

What's hot

Principles of Antiepileptic therapy in focal epilepsy
Principles of Antiepileptic therapy in focal epilepsyPrinciples of Antiepileptic therapy in focal epilepsy
Principles of Antiepileptic therapy in focal epilepsyPramod Krishnan
 
Withdrawal of anti epileptic drugs
Withdrawal of anti epileptic drugsWithdrawal of anti epileptic drugs
Withdrawal of anti epileptic drugsPramod Krishnan
 
Refractory epilepsy in children
Refractory epilepsy in children Refractory epilepsy in children
Refractory epilepsy in children Khaled Saad
 
starting and continuing treatment in epilepsy
starting and continuing treatment in epilepsystarting and continuing treatment in epilepsy
starting and continuing treatment in epilepsysankalpgmc8
 
Restorative therapy in stroke
Restorative therapy in strokeRestorative therapy in stroke
Restorative therapy in strokeNeurologyKota
 
Monitoring the Multiple Sclerosis patient
Monitoring the Multiple Sclerosis patientMonitoring the Multiple Sclerosis patient
Monitoring the Multiple Sclerosis patientPramod Krishnan
 
migraine management guidelines )
migraine management guidelines )migraine management guidelines )
migraine management guidelines )NeurologyKota
 
When to start and when to stop AEDs
When to start and when to stop AEDsWhen to start and when to stop AEDs
When to start and when to stop AEDsPramod Krishnan
 
Antiepileptics
AntiepilepticsAntiepileptics
AntiepilepticsAmit Kumar
 
Management of seizures
Management of seizuresManagement of seizures
Management of seizuresPraveen Nagula
 
Zonisamide in parkinsons disease
Zonisamide in parkinsons diseaseZonisamide in parkinsons disease
Zonisamide in parkinsons diseasePramod Krishnan
 
Generalised Convulsive Status Epilepticus
Generalised Convulsive Status EpilepticusGeneralised Convulsive Status Epilepticus
Generalised Convulsive Status EpilepticusPramod Krishnan
 
Treatment of epilepsy polytherapy vs monotherapy
Treatment of epilepsy polytherapy vs monotherapyTreatment of epilepsy polytherapy vs monotherapy
Treatment of epilepsy polytherapy vs monotherapyPramod Krishnan
 
Diagnosis of MS and related disorders in children - Cheryl Hemingway
Diagnosis of MS and related disorders in children - Cheryl HemingwayDiagnosis of MS and related disorders in children - Cheryl Hemingway
Diagnosis of MS and related disorders in children - Cheryl HemingwayMS Trust
 
Responsive Neurostimulation (RNS) for Intractable Epilepsy
Responsive Neurostimulation (RNS) for Intractable EpilepsyResponsive Neurostimulation (RNS) for Intractable Epilepsy
Responsive Neurostimulation (RNS) for Intractable EpilepsyAllina Health
 
Vitamins and nervous system
Vitamins and nervous system  Vitamins and nervous system
Vitamins and nervous system NeurologyKota
 

What's hot (20)

Principles of Antiepileptic therapy in focal epilepsy
Principles of Antiepileptic therapy in focal epilepsyPrinciples of Antiepileptic therapy in focal epilepsy
Principles of Antiepileptic therapy in focal epilepsy
 
Withdrawal of anti epileptic drugs
Withdrawal of anti epileptic drugsWithdrawal of anti epileptic drugs
Withdrawal of anti epileptic drugs
 
oral drugs in multiple sclerosis
oral drugs in multiple sclerosisoral drugs in multiple sclerosis
oral drugs in multiple sclerosis
 
Refractory epilepsy in children
Refractory epilepsy in children Refractory epilepsy in children
Refractory epilepsy in children
 
Refractory epilepsy
Refractory epilepsyRefractory epilepsy
Refractory epilepsy
 
starting and continuing treatment in epilepsy
starting and continuing treatment in epilepsystarting and continuing treatment in epilepsy
starting and continuing treatment in epilepsy
 
Restorative therapy in stroke
Restorative therapy in strokeRestorative therapy in stroke
Restorative therapy in stroke
 
Monitoring the Multiple Sclerosis patient
Monitoring the Multiple Sclerosis patientMonitoring the Multiple Sclerosis patient
Monitoring the Multiple Sclerosis patient
 
migraine management guidelines )
migraine management guidelines )migraine management guidelines )
migraine management guidelines )
 
When to start and when to stop AEDs
When to start and when to stop AEDsWhen to start and when to stop AEDs
When to start and when to stop AEDs
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
 
Management of seizures
Management of seizuresManagement of seizures
Management of seizures
 
Zonisamide in parkinsons disease
Zonisamide in parkinsons diseaseZonisamide in parkinsons disease
Zonisamide in parkinsons disease
 
Generalised Convulsive Status Epilepticus
Generalised Convulsive Status EpilepticusGeneralised Convulsive Status Epilepticus
Generalised Convulsive Status Epilepticus
 
Treatment of epilepsy polytherapy vs monotherapy
Treatment of epilepsy polytherapy vs monotherapyTreatment of epilepsy polytherapy vs monotherapy
Treatment of epilepsy polytherapy vs monotherapy
 
Diagnosis of MS and related disorders in children - Cheryl Hemingway
Diagnosis of MS and related disorders in children - Cheryl HemingwayDiagnosis of MS and related disorders in children - Cheryl Hemingway
Diagnosis of MS and related disorders in children - Cheryl Hemingway
 
Status epilepticus
Status epilepticusStatus epilepticus
Status epilepticus
 
Responsive Neurostimulation (RNS) for Intractable Epilepsy
Responsive Neurostimulation (RNS) for Intractable EpilepsyResponsive Neurostimulation (RNS) for Intractable Epilepsy
Responsive Neurostimulation (RNS) for Intractable Epilepsy
 
Drug Resistant Epilepsy
Drug Resistant EpilepsyDrug Resistant Epilepsy
Drug Resistant Epilepsy
 
Vitamins and nervous system
Vitamins and nervous system  Vitamins and nervous system
Vitamins and nervous system
 

Similar to Ms practice guielines

Shorter oral bedaquiline regimen 2022 NTEP guidelines
Shorter oral bedaquiline regimen 2022 NTEP guidelinesShorter oral bedaquiline regimen 2022 NTEP guidelines
Shorter oral bedaquiline regimen 2022 NTEP guidelinesAnkur Gupta
 
Imipramine tablets bp 25mg smpc taj pharmaceuticals
Imipramine tablets bp 25mg  smpc  taj pharmaceuticalsImipramine tablets bp 25mg  smpc  taj pharmaceuticals
Imipramine tablets bp 25mg smpc taj pharmaceuticalsTaj Pharma
 
Multiple myeloma and plasmacytoma
Multiple myeloma and plasmacytomaMultiple myeloma and plasmacytoma
Multiple myeloma and plasmacytomaNilesh Kucha
 
H.5.1-Antipsychotics-PowerPoint-2016.pptx
H.5.1-Antipsychotics-PowerPoint-2016.pptxH.5.1-Antipsychotics-PowerPoint-2016.pptx
H.5.1-Antipsychotics-PowerPoint-2016.pptxssuser03ba7c
 
ADR to Anti Tuberculosis Drugs
ADR to Anti Tuberculosis DrugsADR to Anti Tuberculosis Drugs
ADR to Anti Tuberculosis DrugsGyanshankar Mishra
 
SIDE EFFECTS OF TKIs
SIDE EFFECTS OF TKIsSIDE EFFECTS OF TKIs
SIDE EFFECTS OF TKIsspa718
 
Lenalidomide 5 mg, 10mg, 15mg hard capsules smpc taj pharmaceuticals
Lenalidomide  5 mg, 10mg, 15mg  hard capsules smpc  taj pharmaceuticalsLenalidomide  5 mg, 10mg, 15mg  hard capsules smpc  taj pharmaceuticals
Lenalidomide 5 mg, 10mg, 15mg hard capsules smpc taj pharmaceuticalsTaj Pharma
 
Prednisolone 10mg tablets smpc taj pharmaceuticals
Prednisolone 10mg tablets smpc  taj pharmaceuticalsPrednisolone 10mg tablets smpc  taj pharmaceuticals
Prednisolone 10mg tablets smpc taj pharmaceuticalsTaj Pharma
 
PULSE THERAPY IN DERMATOLOGY.pptx
PULSE THERAPY IN DERMATOLOGY.pptxPULSE THERAPY IN DERMATOLOGY.pptx
PULSE THERAPY IN DERMATOLOGY.pptxPdiangtyGiriMawlong
 
Tuberculosis treatment.pptx
Tuberculosis treatment.pptxTuberculosis treatment.pptx
Tuberculosis treatment.pptxSushil Humane
 
Methylprednisolone 4 mg tablets smpc taj pharmaceuticals
Methylprednisolone 4 mg tablets smpc  taj pharmaceuticalsMethylprednisolone 4 mg tablets smpc  taj pharmaceuticals
Methylprednisolone 4 mg tablets smpc taj pharmaceuticalsTaj Pharma
 
Tuberculosis management in special situations.pptx
Tuberculosis management in special situations.pptxTuberculosis management in special situations.pptx
Tuberculosis management in special situations.pptxRahul Kumar Gupta
 
Amitriptyline 25mg film coated tablets smpc- taj pharmaceuticals
Amitriptyline 25mg film coated tablets smpc- taj pharmaceuticalsAmitriptyline 25mg film coated tablets smpc- taj pharmaceuticals
Amitriptyline 25mg film coated tablets smpc- taj pharmaceuticalsTaj Pharma
 
Antiepileptic drugs
Antiepileptic drugsAntiepileptic drugs
Antiepileptic drugsdrswarupa
 
Clomipramine HCl Tablets SmPC Taj Pharmaceuticals
Clomipramine HCl Tablets SmPC Taj PharmaceuticalsClomipramine HCl Tablets SmPC Taj Pharmaceuticals
Clomipramine HCl Tablets SmPC Taj PharmaceuticalsTajPharmaQC
 
Targeted Therapy in Breast Cancer
Targeted Therapy in Breast CancerTargeted Therapy in Breast Cancer
Targeted Therapy in Breast CancerDr. Shaurya Mehra
 

Similar to Ms practice guielines (20)

Pomalyst showcase 6.5
Pomalyst showcase 6.5Pomalyst showcase 6.5
Pomalyst showcase 6.5
 
Shorter oral bedaquiline regimen 2022 NTEP guidelines
Shorter oral bedaquiline regimen 2022 NTEP guidelinesShorter oral bedaquiline regimen 2022 NTEP guidelines
Shorter oral bedaquiline regimen 2022 NTEP guidelines
 
Imipramine tablets bp 25mg smpc taj pharmaceuticals
Imipramine tablets bp 25mg  smpc  taj pharmaceuticalsImipramine tablets bp 25mg  smpc  taj pharmaceuticals
Imipramine tablets bp 25mg smpc taj pharmaceuticals
 
Multiple myeloma and plasmacytoma
Multiple myeloma and plasmacytomaMultiple myeloma and plasmacytoma
Multiple myeloma and plasmacytoma
 
H.5.1-Antipsychotics-PowerPoint-2016.pptx
H.5.1-Antipsychotics-PowerPoint-2016.pptxH.5.1-Antipsychotics-PowerPoint-2016.pptx
H.5.1-Antipsychotics-PowerPoint-2016.pptx
 
Relapse.Remitting.MS
Relapse.Remitting.MSRelapse.Remitting.MS
Relapse.Remitting.MS
 
ADR to Anti Tuberculosis Drugs
ADR to Anti Tuberculosis DrugsADR to Anti Tuberculosis Drugs
ADR to Anti Tuberculosis Drugs
 
SIDE EFFECTS OF TKIs
SIDE EFFECTS OF TKIsSIDE EFFECTS OF TKIs
SIDE EFFECTS OF TKIs
 
Lenalidomide 5 mg, 10mg, 15mg hard capsules smpc taj pharmaceuticals
Lenalidomide  5 mg, 10mg, 15mg  hard capsules smpc  taj pharmaceuticalsLenalidomide  5 mg, 10mg, 15mg  hard capsules smpc  taj pharmaceuticals
Lenalidomide 5 mg, 10mg, 15mg hard capsules smpc taj pharmaceuticals
 
Prednisolone 10mg tablets smpc taj pharmaceuticals
Prednisolone 10mg tablets smpc  taj pharmaceuticalsPrednisolone 10mg tablets smpc  taj pharmaceuticals
Prednisolone 10mg tablets smpc taj pharmaceuticals
 
PULSE THERAPY IN DERMATOLOGY.pptx
PULSE THERAPY IN DERMATOLOGY.pptxPULSE THERAPY IN DERMATOLOGY.pptx
PULSE THERAPY IN DERMATOLOGY.pptx
 
Tuberculosis treatment.pptx
Tuberculosis treatment.pptxTuberculosis treatment.pptx
Tuberculosis treatment.pptx
 
Methylprednisolone 4 mg tablets smpc taj pharmaceuticals
Methylprednisolone 4 mg tablets smpc  taj pharmaceuticalsMethylprednisolone 4 mg tablets smpc  taj pharmaceuticals
Methylprednisolone 4 mg tablets smpc taj pharmaceuticals
 
Tuberculosis management in special situations.pptx
Tuberculosis management in special situations.pptxTuberculosis management in special situations.pptx
Tuberculosis management in special situations.pptx
 
Amitriptyline 25mg film coated tablets smpc- taj pharmaceuticals
Amitriptyline 25mg film coated tablets smpc- taj pharmaceuticalsAmitriptyline 25mg film coated tablets smpc- taj pharmaceuticals
Amitriptyline 25mg film coated tablets smpc- taj pharmaceuticals
 
Treatment of ibd
Treatment of ibdTreatment of ibd
Treatment of ibd
 
Antiepileptic drugs
Antiepileptic drugsAntiepileptic drugs
Antiepileptic drugs
 
Clomipramine HCl Tablets SmPC Taj Pharmaceuticals
Clomipramine HCl Tablets SmPC Taj PharmaceuticalsClomipramine HCl Tablets SmPC Taj Pharmaceuticals
Clomipramine HCl Tablets SmPC Taj Pharmaceuticals
 
Targeted Therapy in Breast Cancer
Targeted Therapy in Breast CancerTargeted Therapy in Breast Cancer
Targeted Therapy in Breast Cancer
 
Memantine (NAMENDA)
Memantine (NAMENDA)Memantine (NAMENDA)
Memantine (NAMENDA)
 

More from NeurologyKota

CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptxCONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptxNeurologyKota
 
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptxNEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptxNeurologyKota
 
LOCALISATION OF LESION CAUSING COMA.pptx
LOCALISATION OF LESION CAUSING COMA.pptxLOCALISATION OF LESION CAUSING COMA.pptx
LOCALISATION OF LESION CAUSING COMA.pptxNeurologyKota
 
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptxTREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptxNeurologyKota
 
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptxDUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptxNeurologyKota
 
SMART WEARABLE DEVICES IN NEUROLOGY new.pptx
SMART WEARABLE DEVICES IN NEUROLOGY new.pptxSMART WEARABLE DEVICES IN NEUROLOGY new.pptx
SMART WEARABLE DEVICES IN NEUROLOGY new.pptxNeurologyKota
 
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptxASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptxNeurologyKota
 
TRANSCRANIAL DOPPLER (1).pptx
TRANSCRANIAL DOPPLER (1).pptxTRANSCRANIAL DOPPLER (1).pptx
TRANSCRANIAL DOPPLER (1).pptxNeurologyKota
 
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptxINTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptxNeurologyKota
 
EPILEPTIC ENCEPHALOPATHY
 EPILEPTIC ENCEPHALOPATHY  EPILEPTIC ENCEPHALOPATHY
EPILEPTIC ENCEPHALOPATHY NeurologyKota
 
Domain Assessment in Dementia.pptx
Domain Assessment in Dementia.pptxDomain Assessment in Dementia.pptx
Domain Assessment in Dementia.pptxNeurologyKota
 
Young Onset Dementia.pptx
Young Onset Dementia.pptxYoung Onset Dementia.pptx
Young Onset Dementia.pptxNeurologyKota
 
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER NeurologyKota
 
Hyperthermic syndrome in ICU and their management.pptx
Hyperthermic syndrome in ICU and their management.pptxHyperthermic syndrome in ICU and their management.pptx
Hyperthermic syndrome in ICU and their management.pptxNeurologyKota
 
Entrapment Syndromes of Lower Limb.pptx
Entrapment Syndromes of Lower Limb.pptxEntrapment Syndromes of Lower Limb.pptx
Entrapment Syndromes of Lower Limb.pptxNeurologyKota
 
MOG and IgG-4 related Neurological manifestation.pptx
MOG and IgG-4 related Neurological manifestation.pptxMOG and IgG-4 related Neurological manifestation.pptx
MOG and IgG-4 related Neurological manifestation.pptxNeurologyKota
 

More from NeurologyKota (20)

CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptxCONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
 
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptxNEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
 
LOCALISATION OF LESION CAUSING COMA.pptx
LOCALISATION OF LESION CAUSING COMA.pptxLOCALISATION OF LESION CAUSING COMA.pptx
LOCALISATION OF LESION CAUSING COMA.pptx
 
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptxTREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
 
REMOTE ROBOTIC.pptx
REMOTE ROBOTIC.pptxREMOTE ROBOTIC.pptx
REMOTE ROBOTIC.pptx
 
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptxDUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
 
SMART WEARABLE DEVICES IN NEUROLOGY new.pptx
SMART WEARABLE DEVICES IN NEUROLOGY new.pptxSMART WEARABLE DEVICES IN NEUROLOGY new.pptx
SMART WEARABLE DEVICES IN NEUROLOGY new.pptx
 
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptxASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
 
TRANSCRANIAL DOPPLER (1).pptx
TRANSCRANIAL DOPPLER (1).pptxTRANSCRANIAL DOPPLER (1).pptx
TRANSCRANIAL DOPPLER (1).pptx
 
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptxINTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
 
CAROTID WEB.pptx
CAROTID WEB.pptxCAROTID WEB.pptx
CAROTID WEB.pptx
 
CNS IRIS.pptx
CNS IRIS.pptxCNS IRIS.pptx
CNS IRIS.pptx
 
EPILEPTIC ENCEPHALOPATHY
 EPILEPTIC ENCEPHALOPATHY  EPILEPTIC ENCEPHALOPATHY
EPILEPTIC ENCEPHALOPATHY
 
Domain Assessment in Dementia.pptx
Domain Assessment in Dementia.pptxDomain Assessment in Dementia.pptx
Domain Assessment in Dementia.pptx
 
Young Onset Dementia.pptx
Young Onset Dementia.pptxYoung Onset Dementia.pptx
Young Onset Dementia.pptx
 
ENCEPHALOPATHY
ENCEPHALOPATHY ENCEPHALOPATHY
ENCEPHALOPATHY
 
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
 
Hyperthermic syndrome in ICU and their management.pptx
Hyperthermic syndrome in ICU and their management.pptxHyperthermic syndrome in ICU and their management.pptx
Hyperthermic syndrome in ICU and their management.pptx
 
Entrapment Syndromes of Lower Limb.pptx
Entrapment Syndromes of Lower Limb.pptxEntrapment Syndromes of Lower Limb.pptx
Entrapment Syndromes of Lower Limb.pptx
 
MOG and IgG-4 related Neurological manifestation.pptx
MOG and IgG-4 related Neurological manifestation.pptxMOG and IgG-4 related Neurological manifestation.pptx
MOG and IgG-4 related Neurological manifestation.pptx
 

Recently uploaded

Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...narwatsonia7
 
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...Taniya Sharma
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...Neha Kaur
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipurparulsinha
 
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...chandars293
 
Call Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...Taniya Sharma
 
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls ServiceKesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Servicemakika9823
 
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service KochiLow Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service KochiSuhani Kapoor
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableNehru place Escorts
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...aartirawatdelhi
 
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...Arohi Goyal
 
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...narwatsonia7
 
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...narwatsonia7
 
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...narwatsonia7
 
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 

Recently uploaded (20)

Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
 
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Kochi Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
 
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
 
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 6297143586 𖠋 Will You Mis...
 
Call Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Darjeeling Just Call 9907093804 Top Class Call Girl Service Available
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
 
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls ServiceKesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
 
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service KochiLow Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
Low Rate Call Girls Kochi Anika 8250192130 Independent Escort Service Kochi
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
 
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
 
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
 
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
 
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
 
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Aurangabad Just Call 9907093804 Top Class Call Girl Service Available
 

Ms practice guielines

  • 1. MS PRACTICE GUIDELINES Dr prashant shringi AAN recommendations April 23, 2018 ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis2017
  • 2. 1. When to start treatment? –DMT Various subtypes of MS,CIS, RIS 2. Monitoring treatment ? 3. when to switch-DMT? 4. Acute & symptomatic T/t 5. when to stop? 6. Add on drugs or second line drugs for inadequate response or frequent relapses? 7. Special situations –childhood MS,pregnancy,elderly 8. monitoring of individual drug 9. Follow up
  • 3. Q1.When to start treatment? –DMT for Various subtypes of MS,CIS, RIS • Clinically isolated syndrome(CIS) • No / yes • Serial imaging at least annually for the first five years and close follow-up rather than initiating DMT in people with CIS • Offer IFN or glatiramer to patients with CIS and an abnormal MRI with lesions suggestive of MS who do not fulfil criteria for MS (EAN) • First clinical episode ,an event or precedent history that is suggestive of demyelination lasts at least 24hrs and occurs in the absence of fever, infection or encephalopathy
  • 4. • Radiologicallyisolated sydrome(RIS) • No • 34% of patients with RIS develop a first acute clinical event consistent with CIS within 5 years • Incidental brain or spinal cord MRI findings that are highly suggestive of MS in an asymptomatic patient lacking any history ,symptoms or signs of multiple sclerosis
  • 5. DMT for MS • When to start for MS-  fulfilling criteria for MS(Revised Mcdonald’s criteria , MAGNIMS 2016 criteria)  Active lesion on MRI- evidence of inflammation  After discussing the risks and benefits, DMT should be prescribed to people with a single clinical demyelinating event and ≥2 brain lesions characteristic of MS who decide they want this therapy  should offer DMTs to people with relapsing forms of MS with recent clinical relapses or MRI activity
  • 6. Not to start DMT • Serial imaging at least annually for the first five years and close follow-up rather than initiating DMT in people with-  no relapses in the last two years,  no active new MRI lesion
  • 7. Which DMT should start ? • ascertain preferences in terms of safety, route of administration, lifestyle, cost, efficacy, AEs and tolerability in the choice of DMT- pt choice • DMTs are prescribed to reduce relapses and new MRI lesion activity and not for symptom improvement in people with MS • Started with – • INF • glatemir
  • 8. • Highly active MS - prescribe alemtuzumab, fingolimod, or natalizumab • In pt of MS who are candidates for DMTs who do not have access to approved DMTs azathioprine or cladribine should started • Mitoxantrone- Because of the high frequency of severe AEs, clinicians should not prescribe to people with MS unless the potential therapeutic benefits greatly outweigh the risks
  • 9. • SPMS • First rule out other causes of progressive disability in MS- • Mitoxantrone –FDA approved • High dose interferon beta • Almetuzumab • Cyclophosphamide • Cladrbinre • Rituximab ??? • Pulse steroids NO • Ivig
  • 10.
  • 11. • PPMS • should offer ocrelizumab to people with PPMS who are ambulatory • March 2017 • Anti-CD20 mab designed to optomize cell depletion  300mg infusion given 14 days apart(total-600mg) for atleast 120 weeks  C/I in hepatitis B infection
  • 12. Monitoring treatment ? Assesment efficacy of treament • Consider combining MRI with clinical measures when evaluating disease evolution in treated patients • When monitoring treatment response in patients treated with DMDs, perform a reference brain MRI usually within 6 months of treatment onset and compare it with a further brain MRI performed typically 12 months after starting treatment
  • 13. • When monitoring treatment response, measurement of new or unequivocally enlarging T2 lesions is the preferred MRI method supplemented by GAD enhancing lesions for monitoring treatment response When monitoring treatment safety, perform brain MRI yearly in low risk and 3-6 monthly in high risk PML patients
  • 14. Add on drugs or second line drugs for inadequate response or frequent relapses?
  • 15. when consider to switch-DMT? • In following condition one can swtich DMT- • 1. When any pt using a DMT long enough for the treatment to take full effect and are adherent to their therapy when they experience- one or more relapses two or more unequivocally new MRI-detected lesions increased disability on examination, over a one-year period of using a DMT
  • 16. when consider to switch-DMT? 1. change to noninjectable or less frequently injectable DMTs who report intolerable discomfort with the injections or in those who report injection fatigue on injectable DMTs 2. switch DMT or reducing dosage or frequency when there are persistent laboratory abnormalities 3. If a patient develops malignancy or oppurtunistic infection while using a DMT 4. Natalizumab- -pt who have infusion reactions and who experience breakthrough disease activity - should switch DMTs if they have persistent antibodies, check natalizumab antibodies
  • 17. when consider to switch-DMT? • Physician -counsel people considering natalizumab discontinuation that there is an increased risk of MS relapse within six months of discontinuation Level A • initiate treatment(fingolimod, rituximab) within eight to 12 weeks after natalizumab discontinuation
  • 18. When to stop DMT in MS pt ? 1. Pregnancy 2. Trial off therapy- stable MS 3. SPMS-pt who do not have ongoing relapses (or gadolinium-enhanced lesions on MRI activity) and have not been ambulatory (EDSS 7 or greater) for at least two years. Level C 4. CIS- Clinicians should review the associated risks of continuing DMTs versus those of stopping DMTs LevelB
  • 19. Acute & symptomatic T/t • Treatment of acute relapse  IV methylprednisolone (first line therapy)  Plasma exchange (second line therapy) • 5-7 exchanges recommeded on every 2 days, 30- 50ml/kgw Who do not respond to glucocorticoids
  • 20.  Cognitive impairment-DMT  Depression-Duloxetine,escitalopram  Fatigue:Amantidine,Modafinil,Dextroamphetamine,methylpheni  Gait impairment:Dalfampridine (K channel blocker) 10 mg bd, • C/I-if seizure history  Heat intolerance-Dalfampridine  Paroxysmal symptoms- Carbamazepine(CBZ)  Lhermitte sign-gabapentin,pregaba,CBZ  Spasticity- Tizantidine, baclofen, dantrolone, clonezepam
  • 21. Special situations • Pregnancy – • All DMTs are not licensed during pregnancy, except glatiramer,INF • counsel women to stop their DMT before conception for planned pregnancies and should not initiate DMTs during pregnancy unless the risk of MS activity during pregnancy outweighs the risk associated with the specific DMT during pregnancy • Pregnancy – immunomodulatory effect on MS – decreased relapse rate
  • 22. • EAN women with persistent high disease activity, advise to delay pregnancy. If despite this advice, still decide to become pregnant:  treatment with natalizumab throughout pregnancy may be considered  treatment with alemtuzumab could be an alternative, provided that a 4-month interval is strictly observed from the latest infusion until conception
  • 23. • Breast feeding – DMT should be Stop • OCP- can be used in MS • Some studies- OCP reduced relapse
  • 24. • Chidhood MS: • 6-18% before 18 yr • First symptom ADEM like presentation –relapse-MS • Female=male • Nearly always RRMS type • Relapse rate is more than adults • Prognosis is good than adult MS • Treatment – same as adult MS
  • 25. Dose & monitoring of individual drug • INF: • Interferon beta-1b 8 mIU subcutaneous alternate day • Interferon beta-1a 30 micrograms IM weekly • Interferon beta-1a 44 micrograms subcutaneous 3 times per week • A/E: Postinjection flulike symptoms Depression, suicidal ideation, or psychosis. Hepatic injury, Anaphylaxis, Decreased peripheral blood counts • Monitoring : CBC, LFT
  • 26. • Glatiramer Acetate: • 40 mg SQ injection TIW • A/E: Lipoatrophy and skin necrosis,Postinjection reaction - flushing, chest pain, palpitations, anxiety, dyspnea, throat constriction, or urticaria • No laboratory monitoring is neccessary • Natalizumab: infusion • 300 mg IV over one h every 4 wk • A/E: Anaphylaxis .Risk of PML.Herpes encephalitis or meningitis,Hepatotoxicity • Monitoring : JC virus ab in every months
  • 27. • Fingolimod:oral 0.5mg/day • A/E: bradycardia, herpesvirus infections, basal cell skin cancer, macular edema, and abnormal pulmonary function test • Monitoring : CBC, pre-screening for VZV immunity, ophthalmologic evaluation to screen for macular edema, and ECG testing to rule out cardiac conduction abnormalities Teriflunomide:7 or 14 mg RRMS A/E :Increased blood pressure,Alopecia, nHeadache, Diarrhea, Severe liver injury. Monitoring: patients should be screened for latent tuberculosis and women of childbearing potential should undergo pregnancy testing. Liver function tests should be obtained monthly during the first 6 months of treatment, and intermittently thereafter.
  • 28. • Dimethyl fumarate • 240 mg BD/TDS • A/E:lymphopenia , Flushing, abdominal pain, and diarrhea, Angioedema and anaphylaxis • Monitoring :CBC
  • 29.
  • 30.
  • 31. Follow up Clinical follow up –acute attacks Cognitive assessment EDSS every 3 months MRI every 12 months Modified Rio score
  • 32.
  • 33.
  • 34. Newer therapeutic agents S1P Receptor Modulators Siponimod ,ozanimod Anti-LINGO ab: opicinumab Idebenone  MIS416 Ofatumumab:anti CD 20 antibody
  • 35. • Risk of developing PML in JC ab negative pt on natalizumab ? • 10-20% annualy • 2-3% annualy • 50% annualy • No risk
  • 36. • Which drug not required laboratory montoring? • Teriflunamide • Inf • Glatemir • Alemetezumab
  • 37. • Highly active MS which drug is beneficial? • Inf • Azathipirone • Fingolimod • Glatemir
  • 38. • 40 year old female develpoed one attack of MS started on DMT improved developed 2 attack after 1 year than DMT switched but her weakness worsen continiously , CONTRAST MRI showed no new lesions what next? • Add 2 line drug • Continue same DMT • Start ocrelizumab • Nothing